![]() Cardiorentis Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases. | ![]() AdoRx Therapeutics AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway. | ![]() San Rocco Therapeutics San Rocco Therapeutics (formerly known as Errant Gene Therapeutics (EGT) is a company developing treatments for life-threatening diseases recognized as rare disorders or orphan diseases. | Temisis Therapeutics Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component. | ||
Founding Date | Founding Date 2012 | Founding Date N/A | Founding Date N/A | Founding Date 2003 | Founding Date N/A |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Tilburg, NL HQ | Locations Zug, CH HQ Freienbach, CH | Locations Edinburgh, GB HQ | Locations Chicago, US HQ Roma, IT New York, US Los Angeles, US | Locations Vandœuvre-lès-Nancy, FR HQ |
Employees | Employees 12 | Employees N/A | Employees N/A | Employees 4 | Employees 2 |
Funding | |||||
Latest funding round | Latest funding round $ 55.8k (about 11 years ago) | Latest funding round N/A | Latest funding round $ 10m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 55.8k | Total funding raised $ 118.5m | Total funding raised $ 10m | Total funding raised N/A | Total funding raised N/A |

Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
View company
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
View company
San Rocco Therapeutics (formerly known as Errant Gene Therapeutics (EGT) is a company developing treatments for life-threatening diseases recognized as rare disorders or orphan diseases.
View companyTemisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.
View company